Announcements Trials

Browse Landscape

Status

Completed 8 Terminated 3 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Ovarian Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tobacco Use Disorder 1 Recurrence 1 Precancerous Conditions 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hirschsprung Disease 1 Glioma 1 Ganglion Cysts 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Immunohistochemistry × Clear all

NCT03820921 2019-01-29

SUCCESS

Ponderas Academic Hospital

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡